The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics as well as the legalization of both medicinal and recreational use in a growing number of states. As a result, M&A activity in the market is heading toward exponential growth as well. Acquisitions help public companies diversify their portfolios and revenue streams while providing private companies access to more financing. Public companies such as SinglePoint, Inc. (SING) (SING Profile), Vinergy Resources Ltd. (VNNYF) and ChineseInvestors.com, Inc. (CIIX) have already initiated or completed such acquisitions, encouraged by the significant growth potential that cannabis-based product manufacturing businesses bring to the table. This impressive potential is perfectly exemplified by GW Pharmaceuticals plc (GWPH), a biopharma company focused on developing cannabinoid prescription medicines.
With a reputation as the world’s largest company involved in the production and commercialization of cannabis-based therapeutics, GW Pharmaceuticals (GWPH) has operations in Europe, Canada, the United States and Asia. Based on its proprietary cannabinoid product platform, GW Pharma has developed therapies for the treatment of various conditions, including multiple sclerosis-related spasticity and neuropathic pain. Its product pipeline is also targeting tuberculosis sclerosis complex, infantile spasms, adult epilepsy, schizophrenia and more. But GW Pharma is one of the few developers of cannabis-based products or therapies that are publicly traded, given the legal hurdles and the lingering public misconceptions facing the industry. This is why a large number of growers, dispensaries and product companies choose to…
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer